3Liu Z,Jiang M,Yan F,et al.Multipoint quantification of multimarker genes in periphenal blood and micrometastasis characteristic in peri-operative esophageal cancer patients[J].Cance Lett,2008,26(1):46-54. 被引量：1
5Rauthe G.Sistermanus J.Recombinant turnout necrosis factor in the local therapy of malignant pleural effusion[J].Eur J Cancer,1997,33(2):226-231. 被引量：1
10Shimizut,Takahashi,Terakadom,et al.Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients[J].Gan To Kagaku Ryoho,2005,32(8):1139-1143. 被引量：1
6[1]Rosenberg S A.Adoptive immunotherapy for cancer[J].Scienttific American,1990,262(5):62. 被引量：1
7[2]Inoue Y. Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients[J].Jpn J Cancer Res,1990,81:1 012. 被引量：1
8[3]Freedman R S,Edwards C L,Kavanagh J J,et al.Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2:a pilot trial[J].J Immunother Emphasis Tumor Immunol,1994,16(3):198.210. 被引量：1
9[6]Echchakir H,Asselin-Paturel C,Dorothee G,et al.Analysis of T-cell-receptor beta-chain-gene usape in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas[J].Int J Cancer,1999,81(2):205-213. 被引量：1
